Global Recombinant DNA Technology Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Report ID: GIR2201100631 | Category: Medical Care | Pages: 111 | Format: PDF | Published Date: July 27,2022

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

The Recombinant DNA Technology market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Recombinant DNA Technology market size is estimated to be worth US$ 505 million in 2021 and is forecast to a readjusted size of USD 653.1 million by 2028 with a CAGR of 3.7% during review period. Biotechnology and Pharmaceutical Companies accounting for  % of the Recombinant DNA Technology global market in 2021, is projected to value USD   million by 2028, growing at a  % CAGR in next six years. While Therapeutic Agent segment is altered to a  % CAGR between 2022 and 2028.
Global key companies of Recombinant DNA Technology include Monsanto Company, Roche, Biogen, Amgen, and Novartis, etc. In terms of revenue, the global top four players hold a share over  % in 2021.
Market segmentation
Recombinant DNA Technology market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
    Therapeutic Agent
    Vaccine
    Biotech Crops
    Specialty Chemicals
Market segment by Application, can be divided into
    Biotechnology and Pharmaceutical Companies
    Academic & Government Research Institutes
    Others
Market segment by players, this report covers
    Monsanto Company
    Roche
    Biogen
    Amgen
    Novartis
    Eli Lilly and Company
    GenScript
    Pfizer Inc.
    Novo Nordisk
    Sanofi
    Merck KGaA
    Profacgen
    Biocon
    GlaxoSmithKline
    Cibus
    Horizon Discovery Group
    New England Biolabs
Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Recombinant DNA Technology product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Recombinant DNA Technology, with revenue, gross margin and global market share of Recombinant DNA Technology from 2019 to 2022.
Chapter 3, the Recombinant DNA Technology competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Recombinant DNA Technology market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Recombinant DNA Technology research findings and conclusion, appendix and data source.

1 Market Overview
    1.1 Product Overview and Scope of Recombinant DNA Technology
    1.2 Classification of Recombinant DNA Technology by Type
        1.2.1 Overview: Global Recombinant DNA Technology Market Size by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Global Recombinant DNA Technology Revenue Market Share by Type in 2021
        1.2.3 Therapeutic Agent
        1.2.4 Vaccine
        1.2.5 Biotech Crops
        1.2.6 Specialty Chemicals
    1.3 Global Recombinant DNA Technology Market by Application
        1.3.1 Overview: Global Recombinant DNA Technology Market Size by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Biotechnology and Pharmaceutical Companies
        1.3.3 Academic & Government Research Institutes
        1.3.4 Others
    1.4 Global Recombinant DNA Technology Market Size & Forecast
    1.5 Global Recombinant DNA Technology Market Size and Forecast by Region
        1.5.1 Global Recombinant DNA Technology Market Size by Region: 2017 VS 2021 VS 2028
        1.5.2 Global Recombinant DNA Technology Market Size by Region, (2017-2022)
        1.5.3 North America Recombinant DNA Technology Market Size and Prospect (2017-2028)
        1.5.4 Europe Recombinant DNA Technology Market Size and Prospect (2017-2028)
        1.5.5 Asia-Pacific Recombinant DNA Technology Market Size and Prospect (2017-2028)
        1.5.6 South America Recombinant DNA Technology Market Size and Prospect (2017-2028)
        1.5.7 Middle East and Africa Recombinant DNA Technology Market Size and Prospect (2017-2028)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Recombinant DNA Technology Market Drivers
        1.6.2 Recombinant DNA Technology Market Restraints
        1.6.3 Recombinant DNA Technology Trends Analysis
2 Company Profiles
    2.1 Monsanto Company
        2.1.1 Monsanto Company Details
        2.1.2 Monsanto Company Major Business
        2.1.3 Monsanto Company Recombinant DNA Technology Product and Solutions
        2.1.4 Monsanto Company Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.1.5 Monsanto Company Recent Developments and Future Plans
    2.2 Roche
        2.2.1 Roche Details
        2.2.2 Roche Major Business
        2.2.3 Roche Recombinant DNA Technology Product and Solutions
        2.2.4 Roche Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.2.5 Roche Recent Developments and Future Plans
    2.3 Biogen
        2.3.1 Biogen Details
        2.3.2 Biogen Major Business
        2.3.3 Biogen Recombinant DNA Technology Product and Solutions
        2.3.4 Biogen Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.3.5 Biogen Recent Developments and Future Plans
    2.4 Amgen
        2.4.1 Amgen Details
        2.4.2 Amgen Major Business
        2.4.3 Amgen Recombinant DNA Technology Product and Solutions
        2.4.4 Amgen Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.4.5 Amgen Recent Developments and Future Plans
    2.5 Novartis
        2.5.1 Novartis Details
        2.5.2 Novartis Major Business
        2.5.3 Novartis Recombinant DNA Technology Product and Solutions
        2.5.4 Novartis Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.5.5 Novartis Recent Developments and Future Plans
    2.6 Eli Lilly and Company
        2.6.1 Eli Lilly and Company Details
        2.6.2 Eli Lilly and Company Major Business
        2.6.3 Eli Lilly and Company Recombinant DNA Technology Product and Solutions
        2.6.4 Eli Lilly and Company Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.6.5 Eli Lilly and Company Recent Developments and Future Plans
    2.7 GenScript
        2.7.1 GenScript Details
        2.7.2 GenScript Major Business
        2.7.3 GenScript Recombinant DNA Technology Product and Solutions
        2.7.4 GenScript Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.7.5 GenScript Recent Developments and Future Plans
    2.8 Pfizer Inc.
        2.8.1 Pfizer Inc. Details
        2.8.2 Pfizer Inc. Major Business
        2.8.3 Pfizer Inc. Recombinant DNA Technology Product and Solutions
        2.8.4 Pfizer Inc. Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.8.5 Pfizer Inc. Recent Developments and Future Plans
    2.9 Novo Nordisk
        2.9.1 Novo Nordisk Details
        2.9.2 Novo Nordisk Major Business
        2.9.3 Novo Nordisk Recombinant DNA Technology Product and Solutions
        2.9.4 Novo Nordisk Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.9.5 Novo Nordisk Recent Developments and Future Plans
    2.10 Sanofi 
        2.10.1 Sanofi Details
        2.10.2 Sanofi Major Business
        2.10.3 Sanofi Recombinant DNA Technology Product and Solutions
        2.10.4 Sanofi Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.10.5 Sanofi Recent Developments and Future Plans
    2.11 Merck KGaA
        2.11.1 Merck KGaA Details
        2.11.2 Merck KGaA Major Business
        2.11.3 Merck KGaA Recombinant DNA Technology Product and Solutions
        2.11.4 Merck KGaA Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.11.5 Merck KGaA Recent Developments and Future Plans
    2.12 Profacgen
        2.12.1 Profacgen Details
        2.12.2 Profacgen Major Business
        2.12.3 Profacgen Recombinant DNA Technology Product and Solutions
        2.12.4 Profacgen Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.12.5 Profacgen Recent Developments and Future Plans
    2.13 Biocon
        2.13.1 Biocon Details
        2.13.2 Biocon Major Business
        2.13.3 Biocon Recombinant DNA Technology Product and Solutions
        2.13.4 Biocon Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.13.5 Biocon Recent Developments and Future Plans
    2.14 GlaxoSmithKline
        2.14.1 GlaxoSmithKline Details
        2.14.2 GlaxoSmithKline Major Business
        2.14.3 GlaxoSmithKline Recombinant DNA Technology Product and Solutions
        2.14.4 GlaxoSmithKline Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.14.5 GlaxoSmithKline Recent Developments and Future Plans
    2.15 Cibus
        2.15.1 Cibus Details
        2.15.2 Cibus Major Business
        2.15.3 Cibus Recombinant DNA Technology Product and Solutions
        2.15.4 Cibus Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.15.5 Cibus Recent Developments and Future Plans
    2.16 Horizon Discovery Group
        2.16.1 Horizon Discovery Group Details
        2.16.2 Horizon Discovery Group Major Business
        2.16.3 Horizon Discovery Group Recombinant DNA Technology Product and Solutions
        2.16.4 Horizon Discovery Group Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.16.5 Horizon Discovery Group Recent Developments and Future Plans
    2.17 New England Biolabs
        2.17.1 New England Biolabs Details
        2.17.2 New England Biolabs Major Business
        2.17.3 New England Biolabs Recombinant DNA Technology Product and Solutions
        2.17.4 New England Biolabs Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.17.5 New England Biolabs Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Recombinant DNA Technology Revenue and Share by Players (2019, 2020, 2021, and 2022)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Recombinant DNA Technology Players Market Share in 2021
        3.2.2 Top 10 Recombinant DNA Technology Players Market Share in 2021
        3.2.3 Market Competition Trend
    3.3 Recombinant DNA Technology Players Head Office, Products and Services Provided
    3.4 Recombinant DNA Technology Mergers & Acquisitions
    3.5 Recombinant DNA Technology New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Recombinant DNA Technology Revenue and Market Share by Type (2017-2022)
    4.2 Global Recombinant DNA Technology Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
    5.1 Global Recombinant DNA Technology Revenue Market Share by Application (2017-2022)
    5.2 Global Recombinant DNA Technology Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
    6.1 North America Recombinant DNA Technology Revenue by Type (2017-2028)
    6.2 North America Recombinant DNA Technology Revenue by Application (2017-2028)
    6.3 North America Recombinant DNA Technology Market Size by Country
        6.3.1 North America Recombinant DNA Technology Revenue by Country (2017-2028)
        6.3.2 United States Recombinant DNA Technology Market Size and Forecast (2017-2028)
        6.3.3 Canada Recombinant DNA Technology Market Size and Forecast (2017-2028)
        6.3.4 Mexico Recombinant DNA Technology Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
    7.1 Europe Recombinant DNA Technology Revenue by Type (2017-2028)
    7.2 Europe Recombinant DNA Technology Revenue by Application (2017-2028)
    7.3 Europe Recombinant DNA Technology Market Size by Country
        7.3.1 Europe Recombinant DNA Technology Revenue by Country (2017-2028)
        7.3.2 Germany Recombinant DNA Technology Market Size and Forecast (2017-2028)
        7.3.3 France Recombinant DNA Technology Market Size and Forecast (2017-2028)
        7.3.4 United Kingdom Recombinant DNA Technology Market Size and Forecast (2017-2028)
        7.3.5 Russia Recombinant DNA Technology Market Size and Forecast (2017-2028)
        7.3.6 Italy Recombinant DNA Technology Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Recombinant DNA Technology Revenue by Type (2017-2028)
    8.2 Asia-Pacific Recombinant DNA Technology Revenue by Application (2017-2028)
    8.3 Asia-Pacific Recombinant DNA Technology Market Size by Region
        8.3.1 Asia-Pacific Recombinant DNA Technology Revenue by Region (2017-2028)
        8.3.2 China Recombinant DNA Technology Market Size and Forecast (2017-2028)
        8.3.3 Japan Recombinant DNA Technology Market Size and Forecast (2017-2028)
        8.3.4 South Korea Recombinant DNA Technology Market Size and Forecast (2017-2028)
        8.3.5 India Recombinant DNA Technology Market Size and Forecast (2017-2028)
        8.3.6 Southeast Asia Recombinant DNA Technology Market Size and Forecast (2017-2028)
        8.3.7 Australia Recombinant DNA Technology Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
    9.1 South America Recombinant DNA Technology Revenue by Type (2017-2028)
    9.2 South America Recombinant DNA Technology Revenue by Application (2017-2028)
    9.3 South America Recombinant DNA Technology Market Size by Country
        9.3.1 South America Recombinant DNA Technology Revenue by Country (2017-2028)
        9.3.2 Brazil Recombinant DNA Technology Market Size and Forecast (2017-2028)
        9.3.3 Argentina Recombinant DNA Technology Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Recombinant DNA Technology Revenue by Type (2017-2028)
    10.2 Middle East & Africa Recombinant DNA Technology Revenue by Application (2017-2028)
    10.3 Middle East & Africa Recombinant DNA Technology Market Size by Country
        10.3.1 Middle East & Africa Recombinant DNA Technology Revenue by Country (2017-2028)
        10.3.2 Turkey Recombinant DNA Technology Market Size and Forecast (2017-2028)
        10.3.3 Saudi Arabia Recombinant DNA Technology Market Size and Forecast (2017-2028)
        10.3.4 UAE Recombinant DNA Technology Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Recombinant DNA Technology Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?